How Does Ebstein ’ s Anomaly Present?
Discussion
Ebstein’s anomaly (EA) accounts for about 0.3-0.5% of all congenital heart disease and about 40% of all tricuspid valve (TV) pathologies. It was first described by Dr. William Ebstein in 1866.
In EA’s simplest form, the TV is displaced inferiorly from the normal hinge points into the right ventricle (RV). This is caused by delamination of both the septal and mural leaflets and they usually form a combined leaflet which can be more adherent to the RV. These anatomical changes causes poor movement of the leaflet(s) and tricuspid regurgitation. Displacement inferiorly can cause decreased RV capacity and...
Source: PediatricEducation.org - March 13, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Post-MI Ventricular Septal Defect Repair Strategies: Each Has Its Place for Now
(MedPage Today) -- BOSTON -- The first registry study to compare percutaneous versus surgical repair of post-infarction ventricular septal defect (VSD) found upfront differences in survival that have an unclear impact on long-term outcomes.... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 18, 2022 Category: Cardiology Source Type: news
How Serious Is Atrial Septal Defect (ASD)?
Title: How Serious Is Atrial Septal Defect (ASD)?Category: Diseases and ConditionsCreated: 12/10/2021 12:00:00 AMLast Editorial Review: 6/9/2022 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - June 9, 2022 Category: Pediatrics Source Type: news
What Are Potential Physical Examination Findings for Patients with Atrioventricular Canal Defects?
Discussion
Atrioventricular canal defects (AVCD) are a heterogeneous range of congenital heart defects (CHD) arising from malformations of intracardiac septal development. Essentially the location where the 4 corners of the 2 atria and 2 ventricula meet is abnormally formed. There is partial or complete fusion of the mitral and tricuspid valves along with atrial (ASD) and ventricular septal defects (VSD). Fusion of the endocardial cushions occurs around 4-5 weeks gestation. The anatomy for an individual is bespoke as the variations of the valve leaflets, chordal attachments and variations in ASD and VSD are numerous. This ...
Source: PediatricEducation.org - March 21, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
atHeart Medical Receives FDA Approval for the Second Phase of the ASCENT ASD U.S. IDE Trial
Company's reSept™ ASD Occluder Aims to Evolve Septal Closure with its Novel Metal-Free Frame Design
BAAR, Switzerland and SANTA CLARA, Calif., Feb. 8, 2022 -- (Healthcare Sales & Marketing Network) -- atHeart Medical, a medical device company dedicated... Devices, Interventional, Cardiology, FDA atHeart Medical, reSept ASD Occluder, atrial septal defect (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 8, 2022 Category: Pharmaceuticals Source Type: news
atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors
BAAR, Switzerland and MOUNTAIN VIEW, Calif., Sept. 8, 2021 -- (Healthcare Sales & Marketing Network) -- atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today announce... Devices, Cardiology, Personnel atHeart Medical, reSept ASD Occluder, atrial septal defect (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 8, 2021 Category: Pharmaceuticals Source Type: news
First Five Patients Successfully Treated with atHeart Medical's Novel reSept(TM) Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial
The first occluder with a metal-free, bioresorbable frame for the treatment of patients with clinically significant, isolated ASDs
BAAR, Switzerland and MOUNTAIN VIEW, Calif., July 14, 2021 -- (Healthcare Sales & Marketing Network) -- atHeart Medical, ... Devices, Interventional, Cardiology atHeart Medical, reSept ASD Occluder, atrial septal defect (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 14, 2021 Category: Pharmaceuticals Source Type: news
Newly Formed Company, atHeart Medical, Aims to Evolve Septal Closure with the reSept(TM) ASD Occluder
Company prepares for U.S. IDE clinical trial of its novel metal-free frame designed to reduce complications and preserve long-term treatment options
BAAR, Switzerland and MOUNTAIN VIEW, Calif., April 20, 2021 -- (Healthcare Sales & Marketing Network) -... Devices, Interventional, Cardiology atHeart Medical, reSept ASD Occluder, atrial septal defect (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2021 Category: Pharmaceuticals Source Type: news
Results from the MITHRAS trial reported at TCT Connect and published in Circulation
(Cardiovascular Research Foundation) The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral valve repair (TMVR) was not superior to conservative medical treatment with regard to the primary endpoint of change in six-minute walking distance. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 15, 2020 Category: International Medicine & Public Health Source Type: news
Poorer Exercise Capacity Persists With Ventricular Septal Defects
FRIDAY, Sept. 25, 2020 -- As they get older, patients with surgically closed or unrepaired congenital ventricular septal defects (VSDs) have poorer exercise capacity than their healthy peers, according to a study published online Sept. 23 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 25, 2020 Category: Pharmaceuticals Source Type: news
Common Heart Defect Limits Exercise Ability: Study
WEDNESDAY, Sept. 23, 2020 -- People born with a hole in their heart may lose 20% or more of their exercise capacity as they age, even if the defect is repaired.
A ventricular septal defect is a hole in the wall separating the heart ' s pumping... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 23, 2020 Category: General Medicine Source Type: news
What Are the Main Acyanotic Congenital Heart Diseases?
Discussion
Congenital heart diseases (CHD) are malformations of the heart and great vessels. It occurs in about 5-8/1000 live births. Cyanotic congenital heart disease is often noted perinatally because of cyanosis, respiratory distress and/or poor feeding or other distress type problems. A review can be found here.
Acyanotic congenital heart disease (ACHD) can present at birth but often is seen in older children or adults unless the lesions are severe, especially obstructive lesions. Severe lesions may also cause cyanosis and distress type problems in patients also.
Shunting lesions cause problems by diverting blood flo...
Source: PediatricEducation.org - August 17, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Carag Receives U.S. FDA IDE Approval to Conduct Clinical Study of First Transcatheter Septal Occluder With Bioresorbable, Metal-free Framework
The U.S. trial for CE-marked CBSO is designed to enroll up to 250 patients in a staged study approach
BAAR, Switzerland, July 1, 2020 -- (Healthcare Sales & Marketing Network) -- CARAG AG, a privately-held Swiss medical device development company, toda... Devices, Interventional, Cardiology, FDA Carag AG, Carag Bioresorbable Septal Occluder, atrial septal defects (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 1, 2020 Category: Pharmaceuticals Source Type: news
What Causes Bradycardia?
Discussion
Bradycardia is a heart rate below what the lowest value that is normal for age. Infants and children have higher heart rates that slowly decrease with age to adult levels. It is usually noted as an incidental finding because of increased vagal tone. Reasons for cardiology referral include associated heart murmur, syncope especially if associated with exercise or unusual triggers, other signs such as chest pain or palpitations, family history of sudden cardiac death, congenital heart disease or familial heart disease, bradycardic medication use, or unusual symptoms associated with the concern. Severe bradycardia ...
Source: PediatricEducation.org - June 22, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
What Causes Tachycardia?
Discussion
Tachycardia is a rapid heart rate that is above normal for age and level of exertion. Tachycardia is common, particularly sinus tachycardia due to normally encountered circumstances such as pain, fever or exercise. It is usually a normal physiologic process but sustained tachycardia often indicates a potentially abnormal underlying cause.
Sinus tachycardia has a rapid heart rate with normal P waves and P-R intervals and variations from moment to moment and respiration. Generally it is not over 200 beats/minute. Vagal stimulation can slow the heart rate; this is a gradual slowing, not an abrupt slowing seen in ...
Source: PediatricEducation.org - March 23, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
